SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Techstars Central LLC, founded in 2006 and based in Boulder, Colorado, operates as a startup accelerator and venture capital firm focused on supporting early-stage technology-oriented companies. It specializes in a mentorship-driven accelerator program, selecting ten startups each summer to participate in a three-month incubation period, offering funding of $120,000 in exchange for equity. Techstars invests primarily in sectors such as fintech, artificial intelligence, blockchain, augmented reality, and IoT, while avoiding investments in medical devices, healthcare technology, and local service-oriented businesses. In addition to its primary accelerator, Techstars has various specialized programs, including those focused on music, retail, mobility, and social impact, with global reach extending to regions such as Africa, Asia, and Latin America. The firm prefers taking minority stakes, typically between six and ten percent, without seeking board representation or investor rights. Techstars has built a robust network of entrepreneurs, mentors, and corporate partners to foster innovation and growth within its portfolio, which includes over 1,000 companies with a significant collective market capitalization.

OrbiMed Advisors LLC is a healthcare-focused investment firm founded in 1989, managing approximately $5 billion in assets. The firm specializes in a range of investment strategies, including private equity, venture capital, and public equity, targeting companies across the healthcare spectrum—from startups to large multinational corporations. OrbiMed invests in various sectors within the healthcare industry, including pharmaceuticals, biotechnology, life sciences, medical devices, and health IT. The firm typically invests between $3 million and $150 million, often seeking majority stakes in its portfolio companies. With a global investment approach, OrbiMed operates from offices in New York, San Francisco, Mumbai, Herzliya, Shanghai, West Kowloon, and Luxembourg, focusing on opportunities in North America, Europe, Asia, and Israel. Its investment strategies are underpinned by fundamental analysis, encompassing investments in public equity, fixed income, and alternative markets.

Qiming Venture Partners is a prominent venture capital firm established in 2006 and headquartered in Shanghai, with additional offices in Beijing, Suzhou, and Hong Kong. The firm specializes in investing in early to growth-stage companies across various sectors, including media and internet, information technology, consumer and retail, healthcare, and clean technology in China. Since its inception, Qiming has built a reputation as a leading investment firm in the region, managing multiple funds with over $1 billion in assets. The firm aims to support promising entrepreneurs and innovative businesses, contributing to the development of China's dynamic economic landscape.

Bpifrance Financement S.A. is a French financial institution that provides a range of financing solutions and support services aimed at fostering the growth of startups, small and medium-sized enterprises (SMEs), and mid-cap companies. It offers various financial products, including medium to long-term loans, export insurance, and leasing options for both tangible and intangible assets. Additionally, Bpifrance supports companies through consulting services, guarantees for bank financing, and training for executives. The organization also engages in direct investments and manages funds aimed at enhancing the financial landscape for businesses at different stages of their development. Established in 1980 and based in Maisons-Alfort, France, Bpifrance was formerly known as OSEO S.A. and rebranded in July 2013. It operates as a subsidiary of Bpifrance SA, reinforcing its commitment to bolstering the French economy through diversified financial solutions.

Sequoia Capital is a prominent venture capital firm founded in 1972 and based in Menlo Park, California. The firm specializes in investing across various stages of startups, including seed, early, and growth stages, and focuses on sectors such as technology, healthcare, financial services, internet, and mobile. Sequoia typically invests between $100,000 and $1 million in seed companies, $1 million to $10 million in early-stage ventures, and $10 million to $100 million in growth investments. The firm operates globally, with significant activities in regions like Israel, China, and India, where it partners with dynamic founders to build successful companies. Sequoia's extensive portfolio includes notable firms and offers valuable insights and resources, benefiting from decades of experience in the venture capital landscape.

Plug and Play, founded in 2006 and based in Sunnyvale, California, operates as a business accelerator and venture capital firm that focuses on early-stage and seed investments in technology startups. The firm runs 12 industry-specific accelerator programs annually, connecting startups with corporate partners and investors to foster collaboration and growth. Plug and Play's investment strategy encompasses a wide range of sectors, including fintech, health and wellness, travel, cybersecurity, and sustainability, allowing it to support diverse startups from any country. The firm provides various resources, including funding, mentorship, office space, and networking opportunities, and has a global presence with offices in North America, Europe, and Asia. Plug and Play has a strong track record, having helped numerous startups secure over $9 billion in funding since its inception. Its programs aim to refine business models and facilitate introductions to potential investors, ultimately contributing to the growth of the startup ecosystem.

General Catalyst Group Management, LLC is a private equity and venture capital firm founded in 2000 and based in Cambridge, Massachusetts, with additional offices in North America and Europe. The firm specializes in early-stage and growth equity investments, focusing on a diverse range of sectors including technology, advanced materials, clean energy, cybersecurity, healthcare, and consumer services. General Catalyst seeks to invest in companies that demonstrate strong growth potential, typically targeting those with an EBITDA between $3 million and $30 million and minimum revenues of $10 million. The firm has managed eight venture capital funds with approximately $3.75 billion in capital commitments. It emphasizes building lasting relationships with entrepreneurs and provides mentorship to foster success, enabling companies to scale effectively. General Catalyst primarily invests in North America and Australia, with a preference for seed investments in Silicon Valley, New York, and Boston.

New Enterprise Associates, Inc. is a private equity and venture capital firm established in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investments across various stages of company development, including seed, start-up, early stage, and later stage, with a focus on sectors such as information technology, healthcare, and energy technology. NEA's investment strategy encompasses a wide range of industries, including consumer internet, software, biotechnology, medical devices, and alternative energy. With over $19 billion in cumulative committed capital, the firm has a notable track record, having participated in more than 210 portfolio company IPOs and over 360 acquisitions. NEA aims to invest between $0.05 million and $20 million, targeting both domestic and international markets, particularly in Asia and the Americas.

RA Capital Management, L.P. is a Boston-based venture capital firm focused on growth capital and early-stage investments in the healthcare and life sciences sectors. Established in 2001, the firm specializes in funding companies involved in drug development, medical devices, diagnostics, and biotechnology. It engages in a range of investment stages, from seed funding to later rounds and public offerings, often preferring to co-invest and take board positions. RA Capital targets companies that are innovating in areas such as prevention, cost-effective diagnostics, genetic testing, and personalized medicine. The firm is staffed by professionals with backgrounds in biology, chemistry, and medicine, providing them with a deep understanding of the scientific and regulatory landscape. This expertise allows RA Capital to identify promising technologies and offer strategic guidance, including potential partnerships and insights into public market demands.

StartUp Health is dedicated to improving global health and well-being through its long-term mission to collaborate with entrepreneurs, known as Health Transformers, in pursuing ambitious health goals termed "health moonshots." Since its inception in 2011, StartUp Health has cultivated a diverse portfolio, currently comprising over 330 companies spanning six continents and 26 countries. These companies focus on various critical health areas, including access to care, reducing costs, curing diseases, addressing women's and children's health, promoting nutrition and fitness, enhancing brain health, mental well-being, addiction recovery, longevity, and pandemic response. The organization is supported by a network of prominent investors and health organizations, positioning it as a leader in health innovation.

Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies that have an alumni connection and an institutional lead investor with relevant expertise. It offers high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who previously lacked access to venture capital opportunities. Alumni Ventures Group invests between $0.01 million and $3 million in various sectors and geographies, without seeking board or observer seats. Additionally, the firm provides focused funds that enable any accredited investor to access a diverse venture portfolio, allowing for investment across different types, sectors, stages, and geographical locations.

Novo Holdings, established in 1999, is the holding company of the Novo Group, primarily managing the investment assets of the Novo Nordisk Foundation. Based in Copenhagen, with additional offices in San Francisco and Boston, Novo Holdings focuses on two main investment categories: Life Science Investments, which encompasses funding life science companies at various stages of development, and Financial Investments, which entails managing a diversified portfolio of equity and fixed income securities. As a prominent life science investor, Novo Holdings aims to create long-term value while ensuring that the Foundation can distribute returns for scientific, social, and humanitarian purposes to enhance public health and welfare. The company has also developed initiatives such as Novo Seeds, which supports early-stage applied research in life sciences, and invests in later-stage life science companies through growth equity. Novo Holdings maintains a strategic influence over affiliated companies, aligning their operations with the values and objectives of the Novo Group.

Perceptive Advisors LLC is an investment management firm founded in 1999 and headquartered in New York City, with an additional office in Boston. The firm specializes in the healthcare sector, focusing on biotechnology, pharmaceuticals, life sciences, diagnostics, digital health, medical devices, and healthcare services. It engages in venture capital and incubation, investing at various stages of a company's life cycle, including seed and Series A funding, as well as late-stage venture and public market investments. Perceptive Advisors employs a long/short equity strategy and utilizes hedging techniques, including equity options and index options, while conducting in-house research to inform investment decisions. The firm also manages separate client-focused equity portfolios and provides customized debt financing solutions through its Perceptive Credit Opportunities Fund. Its clientele includes institutional investors, financial institutions, investment funds, and high-net-worth individuals.

Andreessen Horowitz LLC, founded in 2009 by Marc Andreessen and Ben Horowitz, is a venture capital firm based in Menlo Park, California. The firm specializes in investing across various stages of company development, from seed and early-stage to growth and late-stage ventures. It primarily targets the technology sector, with a strong emphasis on software, cloud computing, and Internet infrastructure. The firm also explores opportunities in consumer and business Internet applications, mobile software, and data storage, as well as at the intersection of computer science and life sciences, particularly in areas like digital therapeutics and computational medicine. Andreessen Horowitz is known for its significant financial backing, with investments typically ranging from $50,000 to $50 million. The firm has established multiple funds, including early-stage funds that focus on a variety of sectors, while explicitly avoiding investments in clean energy, transportation, and certain life sciences domains.

5Y Capital is a private equity and venture capital firm based in Shanghai, China, specializing in seed, startup, early venture, and growth capital investments. Established in 1992, the firm focuses on a diverse range of sectors, including healthcare, technology, fintech, internet services, consumer services, media, and life sciences, among others. It aims to support entrepreneurs in building innovative companies, particularly in China and other emerging markets in Asia/Pacific. Managing approximately USD 5 billion in dual-currency funds, 5Y Capital attracts investments from global sources, including sovereign wealth funds and family offices. The firm typically makes initial investments exceeding USD 500,000 per portfolio company. 5Y Capital operates under the Morningside Group, which is committed to socially responsible investing, particularly in educational opportunities and scientific research.

Khosla Ventures is a venture capital firm established in 2004 by Vinod Khosla, a co-founder of Sun Microsystems. Based in Menlo Park, California, the firm manages over $5 billion and primarily invests in early-stage technology companies throughout the United States. Khosla Ventures provides capital, strategic advice, and venture assistance to entrepreneurs focused on breakthrough innovations across various sectors, including consumer technology, enterprise solutions, health, education, agriculture, and sustainable energy. The firm has a particular interest in high-risk, high-reward opportunities, often acting as a sole investor in "science or innovation experiments." Investment sizes typically range from $100,000 to over $20 million, allowing Khosla Ventures to support both traditional ventures and unconventional projects.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization established in 1982 that focuses on fostering the development and adoption of new technologies in the region. For over 30 years, it has served as a key provider of seed-stage capital, investing more than $170 million in over 1,750 regional technology companies, many of which have achieved industry leadership. In addition to financial support, Ben Franklin promotes university and industry partnerships that facilitate the commercialization of scientific discoveries. The organization is dedicated to strengthening the entrepreneurial ecosystem in Southeastern Pennsylvania, thereby creating jobs and enhancing the technology community.

Scottish Enterprise is Scotland's primary economic development agency, operating as a non-departmental public body under the Scottish Government. Established in 1991 and based in Glasgow, it aims to foster an innovative and productive economy by partnering with both public and private sectors to identify and capitalize on high-value opportunities. The organization supports small and medium-sized enterprises (SMEs) by helping them secure necessary financing, enhancing management capabilities, and facilitating growth. Through its arm, the Scottish Investment Bank, it engages in direct and fund of fund investments, focusing on sectors such as renewable energy, healthcare, technology, and creative industries. It typically invests between £0.01 million and £10 million, utilizing various financial instruments including loans, equity, and mezzanine financing. Scottish Enterprise also collaborates with UK and international investors, including business angels and venture capital groups, to stimulate the funding market in Scotland and enhance the growth potential of Scottish businesses.

Polaris Partners is a venture capital firm founded in 1996 and headquartered in Boston, Massachusetts. With a focus on technology and healthcare sectors, Polaris invests in companies at all stages of development, from inception to profitable growth. The firm has a history of partnering with experienced entrepreneurs and innovators, aiming to enhance the way people live and work. In addition to its Boston headquarters, Polaris has offices in San Francisco and New York, and it actively targets investments in life sciences, biotechnology, and software industries across the United States and Europe. Over its more than two-decade history, Polaris Partners has established itself as a multibillion-dollar investment firm committed to fostering innovation and entrepreneurship.

The Bill & Melinda Gates Foundation is a prominent grant-making organization co-founded by Bill and Melinda Gates in 2000, headquartered in Seattle, Washington, with additional offices in Washington, D.C.; New Delhi, India; Beijing, China; and London, United Kingdom. The foundation focuses on improving global health, enhancing education, and providing support to at-risk families, particularly in the Pacific Northwest. It actively promotes strategies that assist low-income families and works towards greater equality in various sectors. The foundation is also involved in investment management, overseeing an endowment that includes a diverse portfolio primarily in public equity and fixed income markets, while excluding tobacco-related investments. Its trustees include Bill Gates, Melinda Gates, and Warren Buffett.

F Prime, Inc. is a venture capital firm based in Cambridge, Massachusetts, with additional offices in San Francisco and London. Founded in 1969, it is part of the legacy of Fidelity Investments, one of the largest asset management firms in the world. F Prime focuses on investing in North American and European companies across various sectors, including healthcare, life sciences, medtech, technology, and health information technology. The firm operates several specialized funds, such as those dedicated to healthcare and life sciences, which aim to support early-stage companies in these industries. With a commitment to fostering entrepreneurship, F Prime leverages its extensive insights, domain expertise, and relationships to assist entrepreneurs in building impactful companies, all while avoiding the pressures of external fundraising.

GV Management Company, LLC, established in 2009 as the venture capital arm of Alphabet Inc., specializes in investments across various stages, including seed, early, and late-stage funding. Based in Mountain View, California, with additional offices in Boston, New York, Seattle, Cambridge, and London, GV focuses on sectors such as life sciences, healthcare, artificial intelligence, robotics, transportation, cybersecurity, and agriculture. The firm has invested in over 300 companies, aiming to drive innovation and improve lives. GV seeks to make investments of up to $50 million, while offering early-stage startups funding of up to $250,000, typically taking minority stakes in these companies. Through its extensive network, GV provides startups with unique access to technology and talent, enhancing their potential for success.

Mayo Clinic is a not-for-profit medical group practice established in 1864, with its headquarters in Rochester, Minnesota. The organization operates medical care facilities across several states, including Minnesota, Florida, and Arizona, offering a wide range of services in specialties such as diabetes, cancer, neurology, and cardiology. In addition to patient care, Mayo Clinic is deeply involved in medical education, providing various degree and certificate programs, and conducting extensive research to advance healthcare through the development of diagnostic tools, medications, and treatment protocols. The institution emphasizes collaboration between physicians and scientists to foster innovation and improve patient outcomes. As a foundation, its operations are supported by the Mayo Foundation for Medical Education and Research, reinforcing its commitment to enhancing healthcare and education in the medical field.

500 Global, formerly known as 500 Startups, is a venture capital firm and incubator based in Mountain View, California, founded in 2010. The firm specializes in seed investments, primarily focusing on early-stage technology and financial services startups across various sectors, including biotech, e-commerce, fintech, and digital healthcare. 500 Global operates a four-month accelerator program, where it typically invests between $0.05 million and $1 million for a 5 to 10 percent equity stake in companies with at least $100,000 in monthly revenue. The firm targets a global market, with particular emphasis on regions such as the Middle East, Asia, Europe, and Latin America. Since its inception, it has invested in over 2,200 startups and supports the growth of innovation ecosystems through educational programs and partnerships. 500 Global also prioritizes investments in companies led by minority founders, reflecting its commitment to diverse entrepreneurial leadership.

Sofinnova Partners is an independent venture capital firm headquartered in Paris, France, with a focus on the life sciences sector, including biopharmaceuticals, biotechnology, medical devices, and industrial biotechnology. Over its 45-year history, the firm has financed nearly 500 companies, primarily targeting start-ups, early-stage ventures, corporate spin-offs, and occasional turnaround situations. Sofinnova Partners actively sources investment opportunities and often serves as the first institutional investor in Series A financings, taking a lead role in its portfolio companies. The firm engages closely with entrepreneurs from the formation phase, holding board positions and guiding companies through their development until exit. While primarily investing throughout Europe, Sofinnova Partners also allocates a portion of its investments globally.

Legend Capital, founded in 2001 as a subsidiary of Legend Holdings Ltd., is a prominent asset manager based in China. With a focus on private equity investments, the firm manages approximately $700 million across four funds and specializes in early-stage and mid-market growth ventures. Its investment strategy primarily targets high-growth companies with significant operations in China or related markets, particularly in sectors such as information technology, consumer goods, clean technology, healthcare, and equipment manufacturing. Legend Capital is known for its active involvement with portfolio companies, providing comprehensive business resources and tailored services to enhance business development and company visibility in the Chinese market. The firm’s portfolio includes notable companies like Joyo.com, SinoCom, and Solarfun Power, reflecting its commitment to driving innovation and value creation within China's venture capital landscape.

Bessemer Venture Partners is a $4 billion venture capital firm founded in 1911 and based in California, specializing in investments across consumer, enterprise, and healthcare sectors globally, from seed stage to growth. The firm supports founders by providing guidance and resources, starting with seed and Series A investments and maintaining involvement throughout the development of their companies. Bessemer has a diverse portfolio, having funded early-stage companies such as Pinterest, Blue Apron, Skype, and Twitch, and has played a role in the successful initial public offerings of 117 companies, including Twilio, Yelp, and LinkedIn. The firm also operates several specialized funds targeting various sectors, including information technology, software, and digital health, with a presence in key markets such as India and Israel.

Fidelity Investments is a privately owned investment manager based in Boston, Massachusetts, founded in 1946. The firm offers a wide range of financial services, including individual retirement accounts, 401(k) rollovers, annuities, discount brokerage, and wealth management. It serves a diverse clientele, including individual investors, businesses, financial advisors, and institutions. Fidelity manages equity, fixed income, and balanced mutual funds, investing in public equity and fixed income markets worldwide. The firm conducts in-house research to guide its investment decisions and supports over 32 million clients in achieving their financial goals. Additionally, Fidelity assists more than 22,000 businesses with employee benefit programs and collaborates with over 13,000 financial institutions to provide innovative investment and technology solutions.

Deerfield is an investment management firm established in 1994 that specializes in advancing healthcare through investment, information, and philanthropy. With over $8 billion in funds, Deerfield invests broadly in both public and private healthcare sectors, targeting a diverse range of companies from early-stage drug research to established healthcare services and medical device firms. The firm typically maintains equity or debt interests in more than 100 companies. It employs the Deerfield Institute, which conducts extensive research to provide objective market intelligence, engaging with thousands of professionals annually to address complex healthcare challenges. Additionally, a portion of the firm's profits is allocated to the Deerfield Foundation to support various philanthropic initiatives.

HBM Healthcare Investments is a principal investment firm established in 2001 and based in Zug, Switzerland, with a focus on the biotechnology, human medicine, diagnostics, and medical technology sectors. The firm invests globally in approximately 40 mature emerging companies, primarily targeting private firms that demonstrate significant value creation potential. Approximately two-thirds of its portfolio consists of investments in unquoted companies, while the remainder includes public companies and funds. HBM Healthcare Investments has developed a distinctive market position through its strategic investments in firms whose products are either at advanced stages of development or already available in the market. This diversified approach allows the firm to leverage opportunities across Europe, Asia, and North America, contributing to its broad shareholder base and enhancing its investment capabilities.

Optum Ventures is a corporate venture capital firm founded in 2017 and located in Boston, Massachusetts, with an additional office in London. The firm focuses on investing in early-stage companies within the digital health and healthcare sectors that aim to disrupt the traditional healthcare landscape. By leveraging Optum's extensive data resources and industry insights, Optum Ventures provides its portfolio companies with significant advantages, helping them to connect and collaborate with key players in the healthcare ecosystem. The firm seeks to support transformative ideas that can enhance healthcare for everyone, fostering innovation and growth within the industry.

NVP Associates, LLC is a venture capital and private equity firm based in Palo Alto, California, specializing in a diverse range of investment stages and sectors. Established in 1961, the firm focuses on seed, startup, early, mid, and late-stage investments in both listed and unlisted companies, with particular emphasis on technology, healthcare, consumer products, and financial services. NVP Associates seeks to invest between $10 million and $150 million, depending on the stage and nature of the investment, often leading or co-investing with other firms. The firm has a global investment strategy, concentrating on markets in the Asia-Pacific region, the United States, India, Israel, and China. Its portfolio spans various industries, including medical devices, information technology, enterprise software, and digital health. NVP Associates aims to support companies with strong growth potential, leveraging its extensive network and operational expertise to foster development and achieve significant returns.

Founders Fund is a San Francisco-based venture capital firm established in 2005, specializing in investments across various stages, from seed to growth. The firm focuses on transformative technologies and seeks to address significant global challenges through its investments in sectors such as biotechnology, artificial intelligence, aerospace, cybersecurity, and consumer internet. With over $2 billion in capital under management, Founders Fund has a history of backing notable companies, including SpaceX, Palantir, and Facebook, emphasizing a founder-friendly investment strategy that provides substantial support with minimal interference. The firm typically invests between $500,000 and $300 million, targeting innovative companies worldwide.

HealthTech Capital is a group of private investors dedicated to funding and mentoring new "HealthTech" start ups at the intersection of healthcare with the computer and mobility worlds. HealthTech Capital is creating a new ecosystem with leading edge clinical providers, venture firms and other strategic industry players.

Oak HC/FT, founded in 2014 and based in Connecticut, is a distinguished venture growth equity fund specializing in investments within the Healthcare Information & Services and Financial Services Technology sectors. The firm aims to drive transformation in these industries by offering strategic counsel, board-level participation, and access to a comprehensive network of industry leaders. Over the past decade, Oak HC/FT has successfully realized 29 investments, including four initial public offerings, and has seen six of its portfolio companies reach valuations exceeding $1 billion. The firm is led by a team experienced in both healthcare and fintech, reflecting its commitment to developing sector-specific funds and fostering innovative business growth.

Matrix Partners is a venture capital firm established in 1977, with offices in San Francisco, Cambridge, Shanghai, Beijing, Mumbai, and Bangalore. The firm focuses on seed, early-stage, late-stage, and growth capital investments across various sectors, including software, communications, artificial intelligence, fintech, digital health, and clean technology. With a commitment to building long-term relationships with entrepreneurs, Matrix Partners aims to support visionary founders in developing significant, industry-leading companies. The firm has a strong track record, having participated in hundreds of investments, with many of its portfolio companies achieving successful IPOs or profitable mergers and acquisitions. The team at Matrix Partners combines local insights with global expertise, comprising both former entrepreneurs and seasoned investors.

High-Tech Gründerfonds Management GmbH, established in 2005 and based in Bonn, Germany, is a venture capital firm that specializes in early-stage investments in high-tech startups across various sectors, including information and communication technology, software, healthcare, and life sciences. The firm focuses on companies that are less than one year old and have a turnover of less than €10 million. High-Tech Gründerfonds typically invests between €0.5 million and €3 million, acquiring a minority stake of up to 25% in its portfolio companies. The firm often acts as the lead investor and provides follow-on financing, having facilitated over €2 billion in additional funding from external investors. With a commitment to nurturing innovation, it has supported the development of more than 500 startups and has successfully exited over 100 investments. The firm’s backing includes participation from various public and private entities, reflecting its role as a key player in the German startup ecosystem.

Lux Capital Management is a research-driven investment firm based in New York City and Silicon Valley, specializing in founding, seed, early-stage, and growth investments in the physical and life sciences. The firm actively collaborates with entrepreneurs to build successful businesses in high-growth sectors, having created over 20 companies from inception. Lux invests in a diverse range of industries, including 3D printing, artificial intelligence, flying and surgical robots, synthetic biology, genomics, satellites, drones, and computational imaging. With a focus on providing portfolio companies with better connections and deeper insights, Lux Capital aims to accelerate their industry leadership and competitive advantage. The firm manages approximately $4 billion in assets, reflecting its commitment to fostering innovation and growth in emerging technologies.

T. Rowe Price is a publicly owned investment management firm founded in 1937 and headquartered in Baltimore, Maryland. The company serves a diverse clientele that includes individuals, institutional investors, retirement plans, and financial intermediaries. T. Rowe Price offers a wide array of investment strategies encompassing equity, fixed income, and private equity, with a particular focus on funding technology startups. The firm employs a combination of fundamental and quantitative analysis to guide its investment decisions, utilizing both in-house and external research. Additionally, T. Rowe Price is committed to socially responsible investing, prioritizing environmental, social, and governance factors. With a global presence, the firm operates offices in numerous locations worldwide, enhancing its ability to navigate various markets and deliver reliable investment solutions.

Merck & Co., Inc. is a biopharmaceutical company headquartered in Kenilworth, New Jersey, that specializes in developing and delivering medicines and vaccines for a variety of diseases. Established in 1891, the company is committed to discovering innovative products and services that enhance and save lives globally. Merck operates through various divisions, including Merck Research Laboratories, which focuses on developing treatments for cancer and neurodegenerative disorders. Additionally, Merck has investment arms such as the Merck Global Health Innovation Fund and Merck Capital Ventures, which invest in emerging healthcare technology companies and services. These funds support innovations in digital health, diagnostics, and patient engagement, aiming to leverage data to enhance healthcare solutions. Merck's extensive portfolio includes not only pharmaceuticals and vaccines but also consumer and animal health products, making it a significant player in the global healthcare landscape.

Flare Capital Partners is a Boston-based venture capital firm established in 2013, specializing in early-stage and growth equity investments in healthcare technology. The firm focuses on areas such as medical devices, biopharmaceuticals, diagnostics, and digital health technologies, emphasizing transformational solutions that enhance value-based healthcare. Flare Capital Partners is known for its strategic resources and commitment to entrepreneurial success, having raised significant funds dedicated to healthcare innovation. The firm has a diverse portfolio that includes investments in companies like Aetion, Bright Health, and Iora Health. With a keen interest in leveraging mobile solutions and big data analytics, Flare Capital aims to support advancements in healthcare that improve patient outcomes and operational efficiency.

Right Side Capital Management is a venture capital firm based in San Francisco, California, established in 2010. The firm specializes in early-stage investments, focusing exclusively on the pre-seed round of technology startups. Right Side Capital Management aims to support companies with capital-efficient business models that are typically located outside major hubs like the San Francisco Bay Area and New York City. The firm invests in a range of technology sectors, including internet and cloud technologies, and operates primarily within the United States and Canada, with occasional investments in Western Europe, Israel, Australia, and New Zealand. Right Side Capital Management conducts 75 to 100 investments annually, with portfolio companies spanning 19 states. The firm seeks to provide a clear response to entrepreneurs within two weeks, with investments generally ranging from $50,000 to $500,000 and pre-money valuations between $1 million and $3 million.

Questa Capital Management is a healthcare venture growth equity firm based in the United States, established in 2016. The firm focuses on early-stage investments in healthcare and biotech companies throughout North America. Questa Capital seeks to identify disruptive business models that enhance quality of life and improve care efficiency. By partnering with skilled management teams, the firm aims to build innovative market leaders in the healthcare sector. Its mission is to deliver exceptional returns for both investors and management teams.

8VC is a venture capital firm founded in 2015 and headquartered in San Francisco, California. The firm focuses on early-stage investments across various sectors, including healthcare, energy, consumer goods, logistics, biology, IT infrastructure, and government and defense. 8VC aims to catalyze industry transformation by promoting innovative platforms that can replace outdated technology infrastructures, thereby fostering greater innovation and global prosperity. Additionally, the firm manages co-investment funds that target software, telecommunications, media, technology, and 3D printing sectors. With a commitment to enabling significant advancements in these industries, 8VC positions itself as a key player in the venture capital landscape.

Wellington Management Company LLP, founded in 1928 and headquartered in Boston, Massachusetts, is a prominent investment management firm providing comprehensive solutions to institutional clients worldwide. The firm specializes in a diverse range of investment strategies, including equity, fixed income, multi-asset, and alternative investments, tailored to meet the unique return and risk objectives of its clients. Wellington Management employs a collaborative approach, leveraging proprietary research and analytical tools to identify opportunities and manage risks across global capital markets. The firm caters to a wide array of clients, including sovereign institutions, endowments, foundations, wealth managers, and insurance companies, spanning more than 50 countries. With a focus on long-term investment principles, Wellington Management fosters independent thought and debate within its teams, ensuring that resources are effectively utilized to deliver consistent results. The firm also emphasizes environmental, social, and governance (ESG) considerations in its research and investment processes, engaging with companies on key ESG topics.

ARCH Venture Partners, L.P. is a private equity and venture capital firm founded in 1986 and based in Chicago, Illinois, with additional offices across North America and South America. The firm specializes in early-stage and growth capital investments, primarily focusing on life sciences and biotechnology, but also covering a wide array of technology sectors such as advanced materials, communications technologies, and information technology. ARCH is recognized for its role in commercializing innovations developed at academic research institutions and national laboratories. It has raised over $3 billion through ten venture funds and has invested in more than 150 companies, often co-founding them with leading scientists and entrepreneurs. The firm typically invests between $50,000 and $150 million per company, aiming to enter at seed rounds to minimize risk, and seeks a seat on the Board of Directors for its portfolio companies. While primarily investing in the United States, ARCH also targets opportunities in Canada, Europe, and select countries in Asia, focusing on underserved geographic markets rich in scientific research and technological talent.

DreamIt Health is an accelerator program based in Philadelphia, focused on supporting early-stage startups in the healthcare sector, particularly those involved in digital health, medical devices, and diagnostics. Founded in 2008, it aims to assist companies that have already entered the market and demonstrated some level of revenue or pilot projects. The program connects founders with key players in the healthcare industry, including payers, providers, and pharmaceutical companies, facilitating valuable networking opportunities. Startups benefit from an intensive 3-6 month program that offers seed funding, mentorship, office space, and access to a community of entrepreneurs and experienced advisors. Through this structured approach, DreamIt Health has accelerated numerous startups, helping them to gain customers, establish partnerships, and secure additional funding. The firm has a track record of supporting over 320 startups, which have collectively raised significant follow-on funding and achieved considerable valuations.

BoxGroup Services, LLC is a venture capital firm based in New York that focuses on early-stage investments, particularly in pre-seed, seed, and early Series A companies. Established in 2009 by Adam Rothenberg and David Tisch, the firm primarily targets disruptive technology sectors, including health, biotech, food, SaaS, marketplaces, e-commerce, and fintech. BoxGroup typically invests between $50,000 and $500,000, supporting entrepreneurs with innovative visions and teams capable of creating category-defining businesses. While the firm primarily invests in New York City, Silicon Valley, and Los Angeles, it does not limit its geographic focus. BoxGroup does not take board seats or ownership stakes in its portfolio companies, emphasizing a supportive investment approach.

Kurma Partners is a Paris-based venture capital firm established in 2009, focusing on early-stage investments in the healthcare and biotechnology sectors across Europe. The firm specializes in financing innovation from pre-creation to development capital, managing multiple funds, including the Kurma Biofund I, II, and the Kurma Diagnostics fund. Kurma Partners plays a significant role in supporting therapeutic and medical innovations, leveraging connections with leading research institutes and prestigious hospitals. The firm's investment interests encompass a wide range of areas, including oncology, life sciences, digital health, artificial intelligence, and big data, demonstrating a commitment to advancing healthcare technologies.